Zarley Law is pleased to again sponsor innovationIowa, a publication that highlights emerging companies, legacy enterprises, and the wide range of innovation happening in the Hawkeye State.
The perfect patent application lies in a sweet spot of breadth. For your patent to offer optimum protection, it must be narrow enough to gain the USPTO’s approval but also broad enough that it’s difficult for someone to design around your patent and become a competitor.
Innovators are attempting to determine what to do with their European filing strategies with Brexit becoming more of a reality each day. As laid out in my first post on the subject, the availability of the European Patent Convention (EPC) post-Brexit will continue to make..
Congressional Republicans voted Tuesday to repeal FCC rules preventing internet service providers (ISPs) from selling your browsing history to third parties. Last week, the Republican-controlled Senate passed the same legislation, which leaves the final step—President Trump’s..
There’s no question. You know you need to get a patent, trademark, or copyright for your latest work. But what most people don’t know can indeed hurt them. For example, pursuing a relationship with an attorney that’s not an IP lawyer. So you do your research and you’ve found..
On June 26, 2015, 52% of the voting public in the United Kingdom told the European Union that they needed some distance in what is referred to as Brexit. The question facing many businesses is, how does this affect our intellectual property filing strategy going forward?..
To meet the USPTO’s standard of novelty during the patent application process, your invention has to be different than all others that have come before it. If your invention has been publicly disclosed or sold anywhere in the world, it isn’t patentable. But don’t get..
One question that arises for inventors is what will happen to their issued patent rights after their death. Determining who holds the rights to an issued patent after the inventor’s death depends on the actions taken, or not taken, during the inventor’s life.
In 2017, the Biologics Price Competition and Innovation Act (BPCIA) may be affected by a partial or complete repeal, or a revision, of the Affordable Care Act (ACA). The BPCIA is a set of laws enacted in March 2010 that became Title VII of the ACA. The Trump administration..